Form 8-K - Current report:
SEC Accession No. 0001213900-24-109529
Filing Date
2024-12-17
Accepted
2024-12-17 08:40:01
Documents
14
Period of Report
2024-12-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0224944-8k_neuro.htm   iXBRL 8-K 25296
2 PRESS RELEASE, DATED DECEMBER 17, 2024 ea022494401ex99-1_neuro.htm EX-99.1 66243
  Complete submission text file 0001213900-24-109529.txt   274846

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nmtc-20241217.xsd EX-101.SCH 3006
4 XBRL LABEL FILE nmtc-20241217_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE nmtc-20241217_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0224944-8k_neuro_htm.xml XML 3582
Mailing Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344
Business Address 7599 ANAGRAM DR EDEN PRAIRIE MN 55344 (952) 426-1383
NEUROONE MEDICAL TECHNOLOGIES Corp (Filer) CIK: 0001500198 (see all company filings)

EIN.: 270863354 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-40439 | Film No.: 241553744
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)